US Stock MarketDetailed Quotes

Sarepta Therapeutics (SRPT)

Watchlist

21.790
-0.250-1.13%

Close May 5 15:59 ET

22.040
+0.250+1.15%

Pre 04:58 ET

2.30BMarket Cap-3.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sarepta Therapeutics (SRPT) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

15.58%2.2B

-32.73%442.93M

-14.52%399.36M

68.38%611.09M

80.15%744.86M

52.97%1.9B

65.94%658.41M

40.79%467.17M

38.93%362.93M

63.10%413.46M

Operating revenue

15.58%2.2B

-32.73%442.93M

-14.52%399.36M

68.38%611.09M

80.15%744.86M

52.97%1.9B

65.94%658.41M

40.79%467.17M

38.93%362.93M

63.10%413.46M

Cost of revenue

163.12%839.61M

201.36%398.71M

64.44%150.78M

242.48%152.56M

172.09%137.56M

112.25%319.1M

199.49%132.3M

147.64%91.69M

30.54%44.55M

44.38%50.56M

Gross profit

-14.17%1.36B

-91.59%44.23M

-33.80%248.58M

44.02%458.53M

67.34%607.29M

44.82%1.58B

49.21%526.11M

27.37%375.48M

40.19%318.39M

66.10%362.91M

Operating expense

47.74%2.02B

24.66%454.31M

-11.84%311.46M

7.48%342.96M

176.73%907.68M

0.29%1.36B

11.11%364.43M

11.93%353.29M

-11.52%319.09M

-8.01%328M

Selling and administrative expenses

-11.86%491.72M

-21.71%128.3M

-28.32%91.89M

-0.65%137.9M

5.22%133.63M

15.77%557.87M

24.43%163.87M

6.04%128.2M

17.06%138.8M

14.71%127M

-General and administrative expense

-11.86%491.72M

-21.71%128.3M

-28.32%91.89M

-0.65%137.9M

5.22%133.63M

15.77%557.87M

24.43%163.87M

6.04%128.2M

17.06%138.8M

14.71%127M

Research and development costs

89.19%1.52B

62.71%325.34M

-2.49%218.89M

13.75%204.39M

285.96%773.45M

-8.30%804.52M

2.27%199.95M

15.53%224.48M

-25.71%179.69M

-18.43%200.4M

Depreciation amortization depletion

9.02%2.62M

12.65%677K

12.46%677K

10.98%667K

0.00%601K

54.27%2.41M

-21.23%601K

37.13%602K

235.75%601K

237.64%601K

-Depreciation and amortization

9.02%2.62M

12.65%677K

12.46%677K

10.98%667K

0.00%601K

54.27%2.41M

-21.23%601K

37.13%602K

235.75%601K

237.64%601K

Operating profit

-401.62%-657.77M

-353.64%-410.08M

-383.29%-62.88M

16,587.45%115.58M

-960.58%-300.39M

181.43%218.08M

556.57%161.68M

206.50%22.2M

99.47%-701K

125.28%34.91M

Net non-operating interest income expense

-102.72%-1.45M

-218.43%-12.1M

-93.92%816K

-86.35%1.91M

-49.62%7.93M

-16.55%53.38M

-41.24%10.22M

-23.75%13.42M

-12.33%14.01M

21.08%15.73M

Non-operating interest income

-48.88%36.69M

-40.52%8.74M

-54.28%8.38M

-62.10%7.14M

-37.54%12.43M

-16.52%71.77M

-35.06%14.7M

-19.67%18.33M

-11.14%18.84M

3.01%19.9M

Non-operating interest expense

107.38%38.14M

365.79%20.84M

53.82%7.57M

8.20%5.23M

8.09%4.5M

-16.44%18.39M

-14.50%4.48M

-5.95%4.92M

-7.50%4.83M

-34.11%4.17M

Other net income (expense)

-302.54%-43M

91,170.89%143.89M

-8,123.43%-131.99M

13,388.06%36.15M

-891.04%-91.06M

96.62%-10.68M

90.41%-158K

94.64%-1.61M

-99.74%268K

97.63%-9.19M

Gain on sale of security

-471.42%-15.91M

238.02%1.35M

1,374.33%36.74M

24,711.49%36.72M

-9,845.22%-90.73M

-282.38%-2.79M

---981K

---2.88M

--148K

--931K

Special income (charges)

-220.83%-25.15M

19,552.82%142.88M

-11,046.12%-168.02M

--0

98.13%-7.84M

129.08%727K

105.20%1.54M

--0

97.39%-10.1M

-Less：Restructuring and merger&acquisition

435.97%42.01M

1,833.01%12.6M

2,015.96%29.41M

--0

553.17%7.84M

---727K

-176.75%-1.54M

--0

--10.1M

-Less:Other special charges

---16.86M

---155.48M

--138.61M

----

-Write off

--0

----

--0

----

Other non- operating income (expenses)

-3,136.67%-1.94M

-452.08%-338K

-173.15%-702K

-577.50%-573K

-1,631.58%-329K

-100.06%-60K

114.22%96K

39.53%-257K

-99.88%120K

93.33%-19K

Income before tax

-369.28%-702.23M

-262.04%-278.3M

-670.63%-194.05M

1,031.60%153.64M

-1,025.30%-383.52M

150.14%260.77M

325.41%171.74M

202.51%34.01M

193.09%13.58M

108.08%41.45M

Income tax

-56.20%11.19M

-64.15%4.55M

-3,670.13%-14.1M

-707.76%-43.25M

1,100.79%63.99M

60.81%25.54M

340.23%12.69M

-94.91%395K

-23.92%7.12M

31.74%5.33M

Net income

-403.27%-713.41M

-277.84%-282.85M

-635.38%-179.95M

2,947.86%196.89M

-1,338.98%-447.51M

143.89%235.24M

248.37%159.05M

182.10%33.61M

126.98%6.46M

106.99%36.12M

Net income continuous Operations

-403.27%-713.41M

-277.84%-282.85M

-635.38%-179.95M

2,947.86%196.89M

-1,338.98%-447.51M

143.89%235.24M

248.37%159.05M

182.10%33.61M

126.98%6.46M

106.99%36.12M

Minority interest income

Net income attributable to the parent company

-403.27%-713.41M

-277.84%-282.85M

-635.38%-179.95M

2,947.86%196.89M

-1,338.98%-447.51M

143.89%235.24M

248.37%159.05M

182.10%33.61M

126.98%6.46M

106.99%36.12M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-403.27%-713.41M

-277.84%-282.85M

-635.38%-179.95M

2,947.86%196.89M

-1,338.98%-447.51M

143.89%235.24M

248.37%159.05M

182.10%33.61M

126.98%6.46M

106.99%36.12M

Basic earnings per share

-388.66%-7.13

-338.18%-3.93

-614.29%-1.8

2,771.43%2.01

-1,310.53%-4.6

142.59%2.47

117.11%1.65

176.09%0.35

125.93%0.07

106.48%0.38

Diluted earnings per share

-404.70%-7.13

-362.00%-3.93

-629.41%-1.8

2,600.00%1.89

-1,343.24%-4.6

140.34%2.34

97.37%1.5

173.91%0.34

125.93%0.07

106.31%0.37

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	15.58%2.2B	-32.73%442.93M	-14.52%399.36M	68.38%611.09M	80.15%744.86M	52.97%1.9B	65.94%658.41M	40.79%467.17M	38.93%362.93M	63.10%413.46M
Operating revenue	15.58%2.2B	-32.73%442.93M	-14.52%399.36M	68.38%611.09M	80.15%744.86M	52.97%1.9B	65.94%658.41M	40.79%467.17M	38.93%362.93M	63.10%413.46M
Cost of revenue	163.12%839.61M	201.36%398.71M	64.44%150.78M	242.48%152.56M	172.09%137.56M	112.25%319.1M	199.49%132.3M	147.64%91.69M	30.54%44.55M	44.38%50.56M
Gross profit	-14.17%1.36B	-91.59%44.23M	-33.80%248.58M	44.02%458.53M	67.34%607.29M	44.82%1.58B	49.21%526.11M	27.37%375.48M	40.19%318.39M	66.10%362.91M
Operating expense	47.74%2.02B	24.66%454.31M	-11.84%311.46M	7.48%342.96M	176.73%907.68M	0.29%1.36B	11.11%364.43M	11.93%353.29M	-11.52%319.09M	-8.01%328M
Selling and administrative expenses	-11.86%491.72M	-21.71%128.3M	-28.32%91.89M	-0.65%137.9M	5.22%133.63M	15.77%557.87M	24.43%163.87M	6.04%128.2M	17.06%138.8M	14.71%127M
-General and administrative expense	-11.86%491.72M	-21.71%128.3M	-28.32%91.89M	-0.65%137.9M	5.22%133.63M	15.77%557.87M	24.43%163.87M	6.04%128.2M	17.06%138.8M	14.71%127M
Research and development costs	89.19%1.52B	62.71%325.34M	-2.49%218.89M	13.75%204.39M	285.96%773.45M	-8.30%804.52M	2.27%199.95M	15.53%224.48M	-25.71%179.69M	-18.43%200.4M
Depreciation amortization depletion	9.02%2.62M	12.65%677K	12.46%677K	10.98%667K	0.00%601K	54.27%2.41M	-21.23%601K	37.13%602K	235.75%601K	237.64%601K
-Depreciation and amortization	9.02%2.62M	12.65%677K	12.46%677K	10.98%667K	0.00%601K	54.27%2.41M	-21.23%601K	37.13%602K	235.75%601K	237.64%601K
Operating profit	-401.62%-657.77M	-353.64%-410.08M	-383.29%-62.88M	16,587.45%115.58M	-960.58%-300.39M	181.43%218.08M	556.57%161.68M	206.50%22.2M	99.47%-701K	125.28%34.91M
Net non-operating interest income expense	-102.72%-1.45M	-218.43%-12.1M	-93.92%816K	-86.35%1.91M	-49.62%7.93M	-16.55%53.38M	-41.24%10.22M	-23.75%13.42M	-12.33%14.01M	21.08%15.73M
Non-operating interest income	-48.88%36.69M	-40.52%8.74M	-54.28%8.38M	-62.10%7.14M	-37.54%12.43M	-16.52%71.77M	-35.06%14.7M	-19.67%18.33M	-11.14%18.84M	3.01%19.9M
Non-operating interest expense	107.38%38.14M	365.79%20.84M	53.82%7.57M	8.20%5.23M	8.09%4.5M	-16.44%18.39M	-14.50%4.48M	-5.95%4.92M	-7.50%4.83M	-34.11%4.17M
Other net income (expense)	-302.54%-43M	91,170.89%143.89M	-8,123.43%-131.99M	13,388.06%36.15M	-891.04%-91.06M	96.62%-10.68M	90.41%-158K	94.64%-1.61M	-99.74%268K	97.63%-9.19M
Gain on sale of security	-471.42%-15.91M	238.02%1.35M	1,374.33%36.74M	24,711.49%36.72M	-9,845.22%-90.73M	-282.38%-2.79M	---981K	---2.88M	--148K	--931K
Special income (charges)	-220.83%-25.15M	19,552.82%142.88M	-11,046.12%-168.02M	--0	--0	98.13%-7.84M	129.08%727K	105.20%1.54M	--0	97.39%-10.1M
-Less：Restructuring and merger&acquisition	435.97%42.01M	1,833.01%12.6M	2,015.96%29.41M	--0	--0	553.17%7.84M	---727K	-176.75%-1.54M	--0	--10.1M
-Less:Other special charges	---16.86M	---155.48M	--138.61M	----	----	----	----	----	----	----
-Write off	--0	----	----	----	----	--0	--0	--0	----	----
Other non- operating income (expenses)	-3,136.67%-1.94M	-452.08%-338K	-173.15%-702K	-577.50%-573K	-1,631.58%-329K	-100.06%-60K	114.22%96K	39.53%-257K	-99.88%120K	93.33%-19K
Income before tax	-369.28%-702.23M	-262.04%-278.3M	-670.63%-194.05M	1,031.60%153.64M	-1,025.30%-383.52M	150.14%260.77M	325.41%171.74M	202.51%34.01M	193.09%13.58M	108.08%41.45M
Income tax	-56.20%11.19M	-64.15%4.55M	-3,670.13%-14.1M	-707.76%-43.25M	1,100.79%63.99M	60.81%25.54M	340.23%12.69M	-94.91%395K	-23.92%7.12M	31.74%5.33M
Net income	-403.27%-713.41M	-277.84%-282.85M	-635.38%-179.95M	2,947.86%196.89M	-1,338.98%-447.51M	143.89%235.24M	248.37%159.05M	182.10%33.61M	126.98%6.46M	106.99%36.12M
Net income continuous Operations	-403.27%-713.41M	-277.84%-282.85M	-635.38%-179.95M	2,947.86%196.89M	-1,338.98%-447.51M	143.89%235.24M	248.37%159.05M	182.10%33.61M	126.98%6.46M	106.99%36.12M
Minority interest income
Net income attributable to the parent company	-403.27%-713.41M	-277.84%-282.85M	-635.38%-179.95M	2,947.86%196.89M	-1,338.98%-447.51M	143.89%235.24M	248.37%159.05M	182.10%33.61M	126.98%6.46M	106.99%36.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-403.27%-713.41M	-277.84%-282.85M	-635.38%-179.95M	2,947.86%196.89M	-1,338.98%-447.51M	143.89%235.24M	248.37%159.05M	182.10%33.61M	126.98%6.46M	106.99%36.12M
Basic earnings per share	-388.66%-7.13	-338.18%-3.93	-614.29%-1.8	2,771.43%2.01	-1,310.53%-4.6	142.59%2.47	117.11%1.65	176.09%0.35	125.93%0.07	106.48%0.38
Diluted earnings per share	-404.70%-7.13	-362.00%-3.93	-629.41%-1.8	2,600.00%1.89	-1,343.24%-4.6	140.34%2.34	97.37%1.5	173.91%0.34	125.93%0.07	106.31%0.37
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm